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Abstract objective Increasing numbers of children with HIV are surviving to adolescence and encountering
multiple clinical and social consequences of long-standing HIV infection. We aimed to investigate the
association between HIV and disability, social functioning and school inclusion among 6- to 16-year-
olds in Zimbabwe.
methods HIV-infected children receiving antiretroviral therapy from a public-sector HIV clinic and
HIV-uninfected children attending primary care clinics in the same catchment area were recruited.
Standardised questionnaires were used to collect socio-demographic, social functioning and disability
data. Multivariable logistic regression was used to assess the relationship between HIV status and
disability and functioning.
results We recruited 202 HIV-infected and 285 HIV-uninfected children. There was no difference
in age and gender between the two groups, but a higher proportion of HIV-infected children were
orphaned. The prevalence of any disability was higher in HIV-infected than uninfected children
(37.6% vs. 18.5%, P < 0.001). HIV-infected children were more likely to report anxiety (adjusted
odds ratio (aOR) 4.4; 95% CI 2.4, 8.1), low mood (aOR 4.2; 2.1, 8.4) and difficulty forming
friendships (aOR 14.8; 1.9, 116.6) than uninfected children. Children with HIV also reported more
missed school days, repeating a school year and social exclusion in class. These associations remained
apparent when comparing children with HIV and disability to those with HIV but no disabilities.
conclusions Children with HIV commonly experience disabilities, and this is associated with social
and educational exclusion. Rehabilitation and support services are needed to facilitate educational
attainment and social participation in this group.
keywords disability, adolescents, children, Africa, HIV, social functioning
Introduction
Of the estimated 1.8 million children who are infected
with HIV, 90% live in sub-Saharan Africa (SSA) [1]. The
dramatic improvement in survival that has resulted from
the global scale-up of antiretroviral therapy (ART) pro-
grammes has meant that increasing numbers of children
with HIV who would have died without treatment in
infancy are now surviving to older childhood and adoles-
cence. There is increasing evidence that childhood HIV
infection is associated with chronic multi-system compli-
cations, resulting in hearing, cognitive, mobility and
visual impairments [2, 3].
HIV may lead to impairments through sequelae of
infections that occur as a result of immunosuppression.
For example, HIV-mediated immunosuppression leads to
opportunistic infections such as CMV that can result in
visual impairment [4]. The risk of impairments is
increased if initiation of ART is delayed, as is common in
many resource-limited settings [5]. ART itself may also
contribute to impairment; for instance, nucleoside ana-
logue reverse-transcriptase inhibitors (NRTI) commonly
used at the time of ART roll-out for children in sub-
Saharan Africa (SSA) (e.g. stavudine and lamuvidine)
have been linked to hearing loss [6,7]. Zidovudine has
been independently linked to myopathy [8], which may
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lead to physical disability. Once established, impairments
may not necessarily be completely reversed by ART [9].
These impairments may, in turn, negatively impact on
social functioning and schooling [3, 10]. In other words,
HIV or its treatment may lead to disability, which is con-
ceptualised as an individuals’ inability to ‘full and effec-
tive participation in society on an equal basis of others’
because they have an underlying impairment and face
attitudinal and environmental barriers [11]. Social depri-
vation, often associated with HIV infection [12], could
potentially exacerbate disability by further restricting par-
ticipation in society. To optimise the quality of life and
long-term care among those living with HIV and their
families, HIV programmes will need to broaden their
focus and address longer-term consequences of HIV
infection, including the impact on schooling and social
inclusion. Even in the absence of HIV, education and
schooling are a major global concern for children and
adolescents with disabilities, who are substantially less
likely to be enrolled in school and, even when enrolled,
lag behind their peers in educational attainment [13].
HIV is likely to magnify these issues among children.
We conducted a cross-sectional study to investigate the
association between HIV and disability, social function-
ing and school inclusion among HIV-infected children
compared to uninfected peers in Zimbabwe.
Methods
Study setting and participants
HIV-infected children aged 6 to 16 years and receiving
either first or second line ART for at least 6 months were
consecutively recruited from Harare Central Hospital
(HCH); this is the largest public-sector hospital in Har-
are, providing HIV care for more than 3000 children.
Acutely ill children, not residing in Harare and without
guardian consent and/or participant assent, were
excluded. Recruitment was restricted to the first five eligi-
ble participants a day for logistical ease.
A comparison group of HIV-uninfected children aged
6–16 years were recruited from primary health care clin-
ics (PHC) in seven high-density communities in the same
catchment area served by the clinic from which the HIV-
infected participants were enrolled. Provider-initiated
HIV testing and counselling are offered by PHCs to all
attendees regardless of the reason for presentation.
Data collection
Socio-demographic data including age, sex and orphan
status were recorded. Trained research nurses
administered standardised questionnaires to collect data
on disability, education and social functioning. The
Washington Group/UNICEF Child Functioning and Dis-
ability 21-Question Set was administered to children and
their caregivers to assess disability [14]. This question set
is validated for children aged 2–17 years. Difficulty func-
tioning was defined as binary variables based on self-
reported difficulty in the following domains: vision, hear-
ing, walking, speech, learning, memory, self-care, anxiety,
low mood, difficulty controlling behaviour, dealing with
change, forming friendships and concentration. Disability
was defined as reported difficulties in any of the func-
tional domains. Additional information on school and
social functioning was also collected including school
enrolment, school attendance, repeated school grade,
problems getting help from teachers and friends,
Table 1 Baseline characteristics of HIV-infected and HIV-







n (%) P value
Age
Median (IQR) years 11 (8–13) 10 (8–13) 0.61*
6–11 years 132 (65.4) 165 (57.9) 0.06†
12–16 years 70 (34.6) 32 (42.1)
Sex
Female 97 (48.0) 139 (48.8) 0.11†
Orphan status
Single orphan 69 (34.2) 25 (8.8) <0.001†
Double orphan 28 (13.9) 7 (2.5)
Not orphaned 98 (48.5) 245 (85.9)
Age at HIV diagnosis
Median (IQR) years 5 (3–7)
ART duration
<1 year 75 (37.1)
1–5 years 97 (48.0)





<200 cells/ll 9 (4.5)
200–500 cells/ll 47 (23.2)





<400 copies/ml 152 (75.2)
400–5000 copies/ml 14 (7.0)
>5000 copies/ml 32 (15.8)
HIV+, HIV-infected; HIV, HIV-uninfected, SD standard devia-
tion.
*P value from Mann–Whitney U test.
†P value from chi-squared test.
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interaction with other children (leadership, play, bullying)
and inclusion in lessons and school activities. Caregivers
of HIV-infected children were asked additional questions
relating to HIV diagnosis, testing, ART history and chil-
dren’s awareness of diagnosis. CD4 count was deter-
mined using an Alere PIMA CD4+ (Waltham,
Massachusetts, USA), and HIV viral load was measured
using COBAS Ampliprep/Taqman 48 Version 2.0 (Roche,
Rotkreuz, Switzerland).
Ethics
Ethical approval was obtained from the Medical
Research Council of Zimbabwe (MRCZ/A/1856), the
Biomedical Research and Training Institute (AP125),
Institutional Review Board, Harare Hospital Ethics Com-
mittee and the London School of Hygiene and Tropical
Medicine (LSHTM) Ethics Committee (8263). All guar-
dians gave written consent, and participants gave assent
to participate in the study.
Data management and analysis
Data were collected using paper forms and entered into a
Microsoft Access (MSACCESS) database using optical
mark recognition software (Cardiff TELEFORM Intelli-
gent Character, Version 10.7). Paper forms were manu-
ally checked for missing data and inconsistencies before
being captured using TELEFORM which has inbuilt
quality control checks. Further internal and external con-
sistency checks were carried out after the data were
committed into the database using MSACCESS database
queries.
Data completeness was assessed by summary and
descriptive statistics. There was a low proportion of miss-
ing data (<6%) in HIV-infected and negative children for
demographic, clinical, disability and school functioning
and inclusion data. All statistical analyses were carried
out using Stata v13.0 (College Station, Texas: StataCorp
LP). The prevalence of functional difficulties and disabil-
ity by HIV status was summarised as frequencies and per-
centages for each variable. Continuous variables were
summarised as mean (SD) when normally distributed and
median (IQR) when not. Univariable logistic regression
analysis was used to compare functional, school and
social outcomes between HIV-infected and uninfected
children. Multivariable logistic regression was used to
adjust each functional outcome of interest for a priori
defined variables of age and sex. Orphan status and pre-
vious infection/co-morbidity did not significantly affect
the fit of the model (P < 0.05) on likelihood ratio testing
and therefore were excluded. Hence, the final model was
adjusted for age and sex alone.
Results
Baseline characteristics of participants
We recruited 202 HIV-infected children (median age
11 years [IQR 8–13]; 48.8% female) and 285 uninfected
children (median age 10 years [IQR 8–13]; 48.8%
female). There was no significant difference in age or sex







n (%) Crude OR (95% CI) P value‡ aOR (95% CI) P value‡
Any disability 76 (37.6) 53 (18.8) 2.3 (1.6, 5.3) <0.001 2.8 (1.8, 4.2) <0.001
Seeing 16 (7.7) 9 (3.1) 2.7 (1.2, 6.0) 0.009 3.0 (1.3, 6.9) 0.009
Hearing 10 (4.8) 4 (1.4) 3.4 (1.1, 10.6) 0.031 3.4 (1.0, 10.5) 0.036
Walking 5 (2.5) 1 (0.4) 7.4 (0.9, 63.5) 0.065 7.4 (0.9, 63.5) 0.055
Speaking 9 (4.3) 3 (1.1) 4.0 (1.1, 14.5) 0.042 3.8 (1.1, 13.9) 0.042
Learning 48 (23.2) 33 (11.6) 2.1 (1.3, 3.2) 0.002 3.9 (1.4, 3.4) 0.001
Remembering 37 (17.8) 16 (5.6) 3.6 (2.0, 6.6) <0.001 3.5 (2.0, 6.6) <0.001
Self-caring 3 (1.5) 1 (0.4) 1.7 (0.4, 8.0) 0.072 1.6 (0.4, 7.8) 0.524
Anxiety 42 (20.3) 14 (5.6) 4.6 (2.4, 8.2) 0.000 4.4 (2.4, 8.1) <0.001
Depression 32 (15.5) 12 (4.2) 4.2 (2.1, 8.5) 0.010 4.2 (2.1, 8.4) 0.010
Controlling behaviour 3 (1.5) 1 (0.4) 4.0 (0.4, 39.4) <0.001 4.0 (0.4, 39.3) 0.003
Concentration 2 (1.0) 6 (2.1) 0.4 (0.1, 2.2) 0.478 0.4 (0.1, 2.2) 0.311
Accepting change 39 (10.9) 36 (12.6) 1.6 (0.9, 2.6) 0.085 1.5 (1.0, 2.5) 0.075
Making friends 10 (4.8) 1 (0.4) 14.6 (1.9, 115.2) 0.001 14.8 (1.9, 116.6) 0.011
HIV+, HIV-infected; HIV, HIV-uninfected; OR, odds ratio; aOR age, sex-adjusted odds ratio.
‡P value from chi-squared test.
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between the two groups, but HIV-infected children were
more likely to be orphaned (aOR 5.2; 3.5, 7.8) (Table 1).
Among HIV-infected children, the median age at HIV
diagnosis was 5 years [IQR 3–7] and the median dura-
tion of ART was 2 years [IQR 0–5]. The median CD4
count was 726 cells/ll [IQR 476–941].
Functioning and disability
The prevalence of any self-reported difficulties in func-
tioning (i.e. disability) was higher in HIV-infected than
uninfected children (37.6% compared to 18.5%
P < 0.001; Table 2). The most common type of disability
was problems with memory and learning difficulties,
reported by 17.8% and 23%, respectively. Difficulties
with seeing (7.7%), hearing (4.8%) and walking (2.5%)
were less frequent.
After adjustment for age and sex, the odds of any dis-
ability were 2.8 times higher in HIV-infected than
HIV-uninfected children (95% CI 1.8, 4.2 P < 0.001).
HIV-infected children were significantly more likely to
report visual (aOR 3.0; 1.3, 6.9), hearing (aOR 3.4; 1.0,
10.5), speech (aOR 3.8; 1.1, 13.9), learning (aOR 3.9; 1.4,
3.4) and memory problems (aOR 3.5; 2.0, 6.6; Table 2).
In addition, HIV-infected children were more likely to
report anxiety (aOR 4.4; 2.4, 8.1), low mood (aOR 4.2;
2.1, 8.4) and difficulty forming friendships (aOR 14.8;
1.9, 116.6) than their uninfected peers. There was no sig-
nificant association between age at HIV diagnosis, CD4
count, viral load, ART duration or previous co-morbidity
and disability among HIV-infected children (Table 3).
Schooling and social inclusion
School enrolment rates were high among all children
(96.0% in both HIV-infected and uninfected groups).
However, children living with HIV were more likely to
have repeated a school year (aOR 3.2; 1.6, 3.8) and on
Table 3 Difference in HIV characteristics among HIV-infected children with and without disability in Zimbabwe
Characteristic HIV+ with disability: n = 76 HIV+ without disability: n = 126 P value
Age
Mean (SD) years 10.9 (2.6) 10.3 (2.6)
6–9 years 24 (31.6) 48 (38.1) 0.77 -
10–12 years 31 (40.8) 50 (39.7)
13–14 years 15 (19.7) 20 (15.9)
15–16 years 6 (7.9) 8 (6.4)
Age at diagnosis
Mean (SD) years 5.0 (3.0) 5.1 (2.9) -
Sex
Female 35 (46.0) 62 (49.2) 0.66
aOR (95% CI)
CD4 count
Median (IQR) cells/ll 736 (513–914) 720 (459–910)
<200 cells/ll 3 (4.0) 6 (4.7) 0.78 1.0
200–500 cells/ll 15 (19.7) 32 (25.4) 1.4 (0.8, 2.5)
>500 cells/ll 57 (75.0) 87 (69.1)
Viral load
Median (IQR) copies/ml 19 (19–190) 19 (19–343)
<400 copies/ml 57 (75.0) 95 (75.4) 0.16 1.0
400–5000 copies/ml 2 (2.6) 12 (9.5) 1.1 (0.7, 1.6)
>5000 copies/ml 14 (18.4) 18 (14.3)
ART duration
Median (IQR) years 2 (0–5) 1 (0–4)
<1 year 24 (31.6) 51 (40.5) 0.21 1.0
1–5 years 39 (51.3) 58 (46.0) (0.8, 1.9)
>5 years 13 (17.1) 17 (13.5)
No of hospital admissions in 12 months
>1 5 (6.6) 5 (4.0) 1.9 (0.6, 6.1)
Past history of TB 29 (38.2) 50 (39.7) 0.94 0.9 (0.5, 1.6)
HIV+, HIV-infected; HIV, HIV uninfected; aOR, odds ratio adjusted for age and sex; ART, antiretroviral therapy; TB, tuberculosis.
4 © 2017 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
Tropical Medicine and International Health volume 00 no 00
R. Rukuni et al. Disability in HIV-infected school children
average missed more days of school in the preceding
month (mean 0.9 days (range 0–15 days) vs. 0.3 days
(range 0–7 days). HIV-infected children more frequently
reported not getting help from teachers (aOR 2.1; 1.2,
3.8) or friends (aOR 3.0; 2.0, 4.5) at school. They were
more likely to feel excluded in lessons and activities
(aOR 4.7; 2.7, 8.3) and more likely to be hit, hurt or
have nasty things said to them by other children (aOR
3.7; 2.2, 6.0). Among children with HIV, those with dis-
abilities were less likely to be enrolled in the same school
grade as their peers (aOR 3.3; 1.7, 6.1) and more likely
to repeat a school year (aOR 1.9; 1.0, 3.6) than HIV-
infected peers without disability. They were also more
likely to report that their peers did not look up to them
as leaders (aOR 2.1; 1.4, 3.4) and that they experienced
violence from their peers (aOR 2.5; 1.3, 4.8) (Table 4).
Discussion
This study demonstrates a high prevalence of physical and
cognitive functional difficulties in HIV-infected children.
HIV-infected children are more likely to report low mood/
anxiety and difficulty forming friendships, repeating a school
year and to experience poor social support at school, particu-
larly those who have both HIV and disability.
Other studies have reported increased physical, sensory
and cognitive difficulties in HIV-infected children com-
pared to uninfected children [3, 15–21]. In SSA, develop-
mental delay (global, motor and cognitive) is strongly
associated with HIV [2], with prevalence as high as 78%
in some children [21]. A number of studies assessed the
prevalence of motor impairment [17, 18, 20, 22–27] and
cognitive impairment among HIV-infected and uninfected
children [17, 21, 23, 25–27]. However, studies to date
have largely focused on infants and younger children
using differing neurodevelopment assessment measures,
thereby making it difficult to compare findings. Although
studies in high-income countries have also found a detri-
mental effect of childhood HIV on neurocognitive devel-
opment, they have similar limitations [28–30]. Severe
forms of cognitive impairment in children appear to be
decreasing in the post-ART era in high-income countries,
but the prevalence of mild impairment is largely
unchanged and may be increasing [31].
Our study showed that HIV has a negative association
with forming friendships, school progression and inclu-
sion in SSA, and this is worse among children with dis-
ability. A recent cross-sectional study of hearing
impairment in 380 HIV-infected Malawian children with
extensive audiological testing (otoscopy, tympanometry,
transient evoked oto-acoustic emissions and audiometry)
showed that one quarter (24%) of children had hearing
loss, and of those with hearing loss, 23% required a
hearing aid to be fitted. Children with hearing impair-
ment were less likely to attend school and had poorer
emotional and school functioning than HIV-positive chil-
dren without hearing loss. Furthermore, only 40% of
caregivers accurately perceived their child’s hearing loss,
and few had sought treatment, implying that routine
screening may be necessary [10].



















School inclusion as reported by children and their carers
Currently enrolled in school 194 (96.0) 273 (96.0) 0.98 (0.4, 2.5) 71 (93.4) 123 (97.6) 0.3 (0.1, 1.5)
Enrolled in the same grade as peers 102 (50.5) 197 (69.1) 2.4 (1.6, 3.6) 24 (31.6) 78 (61.9) 3.3 (1.7, 6.1)
Ever repeated a year at school 68 (33.7) 53 (18.6) 2.5 (1.6, 3.8) 32 (42.1) 36 (28.6) 1.9 (1.0, 3.6)
Social inclusion at school as reported by children and their carers
No help from teachers, if problem
at school
4 (7.4) 2 (0.7) 2.1 (1.2, 3.8) 2 (2.6) 2 (1.6) 1.7 (0.9, 3.2)
No help from friends, if problem at school 15 (7.4) 3 (1.1) 3.0 (2.0, 4.5) 11 (14.5) 4 (3.2) 1.5 (0.9, 2.4)
Child has no friends to play with 2 (1.0) 1 (0.4) 1.8 (0.7, 5.0) 2 (2.6) 1 (0.8) 1.7 (0.8, 5.7)
Friends look up to child as a leader 108 (53.5) 147 (51.6) 1.1 (0.8, 1.6) 44 (57.9) 41 (32.5) 2.1 (1.4, 3.4)
Other children hit, hurt /say nasty
things to child
58 (28.7) 28 (9.8) 3.7 (2.2, 6.0) 30 (39.5) 28 (22.2) 2.5 (1.3, 4.8)
Child does not feel included in
lessons and activities
6 (3.0) 2 (0.7) 4.7 (2.7, 8.3) 3 (4.0) 3 (2.4) 0.6 (0.1, 3.0)
HIV+, HIV-infected; HIV, HIV Uninfected; aOR, odds ratio adjusted for age and sex.
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Evidence in the wider literature for the link between
disability and HIV disease severity and treatment factors
has been inconsistent. Previous studies have shown an
association between CD4, viral load at enrolment, ART
duration and disability. The above-mentioned study in
Malawi [10] showed that hearing loss was significantly
associated with history of frequent ear infections and ear
drainage, malnutrition, history of HIV, WHO Stage 3 or
4 disease, but not duration of ART or CD4. A recent sys-
tematic review of studies in SSA showed that fifteen of
thirty-one (48%) studies found a statistically significant
dose–response relationship between indicators of disease
progression (CD4 or WHO stage) and disability [2]. Ear-
lier treatment of children may reduce the risk of impair-
ments and consequent disability, but once established,
ART alone will be insufficient to enable children with
HIV to lead healthy lives.
One study reviewed the inclusion of disability within
18 national strategic responses to HIV and AIDS in East-
ern and Southern Africa and identified that 9 of 18 coun-
tries (50%) provided HIV prevention and only 5 of 18
countries (27%) recognised the need for specific impact
mitigation and support services interventions for people
with disabilities [32]. Incorporating disability-inclusive
approaches to HIV prevention, treatment and care may
increase the social participation and school functioning of
children with HIV.
To our knowledge, this is the first study to estimate the
prevalence of disability and its association with school
and social functioning in HIV-infected children. A com-
parison group was included, and participants were not
selected on the basis of symptoms. Limitations of this
study include possible misclassification and/or recall bias
from the use of self-reported outcome measures for func-
tional difficulties and disability without contemporaneous
clinical measures of impairments. There was also no
information available on the nature and cause of these
impairments. In addition, there is the possibility of
selection bias and unknown confounding through the use
of non-probability-based sampling. Unfortunately, socio-
economic data such as household income and size, asset
ownership, caregiver education and food security were
not available which meant that analyses could not be
adjusted for socio-economic status.
Although it is evident that disability is common in
HIV-infected children and has a major impact on their
lives, further epidemiological and operational research
specifically analyses each type of impairment to under-
stand which interventions are required to inform the
design of effective rehabilitation services and guide policy
decisions. Examples of the type of interventions for HIV-
infected children that could be introduced include (i)
routine screening for impairments (ii) linking HIV care to
rehabilitation and additional clinical services (e.g. ENT in
the case of hearing impairment) (iii) interventions to pro-
mote school inclusion and social acceptance among chil-
dren with HIV (e.g. through training of parents, teachers
and peers).
Conclusion
This study suggests that physical and cognitive func-
tional difficulties are common among children with
HIV. These difficulties are associated with school exclu-
sion, including impaired educational progress, difficulty
forming friendships and reduced ability to participate in
lessons and activities. Further work is required to
develop tools to better detect and understand the need
for rehabilitation and support services within paediatric
HIV programmes.
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